Insomnia in Patients Participating in Interdisciplinary Pain Rehabilitation

The main purpose of this project is to conduct a prospective cohort study in order to better understand the importance of insomnia symptoms in patients referred to interdisciplinary rehabilitation due to chronic pain. Moreover, this project will also raise awareness on how insomnia symptoms, alone, and in interplay with factors such as function, psychological distress, physical activity, and fatigue impact on patient's prognosis and work ability. Our aim is that this knowledge can be used to design new interventions and improve rehabilitation programs for this patient group.

Study Overview

Detailed Description

Insomnia is a vast problem among patients with chronic musculoskeletal pain. Despite the close relation between pain and sleep, sleep quality has received little attention in rehabilitation programs for patients with pain. So far, there is a lack of studies investigating the association between insomnia and chronic pain in patients referred to interdisciplinary rehabilitation. Identifying subgroups of the population with higher burden of poor sleep will aid clinicians to tailor treatment and prevention strategies. Moreover, knowledge on how insomnia symptoms fluctuate throughout the rehabilitation program and how insomnia symptoms interact with factors such as mental distress, physical activity, and fatigue impact on patient's recovery (e.g., the prognosis of pain, quality of life, and work participation) can be used to develop and implement more successful rehabilitation programs.

This is a cohort study primarily designed to address sleep problems in patients referred for pain rehabilitation by using questionnaire data from the rehabilitation centers linked to registry data. This study will constitute both a cross-sectional survey among patients referred to rehabilitation before they participate in rehabilitation. In addition to questionnaires, administrative data and clinical data, these data will be linked to national health registries on prescriptions, health care use and sickness absence. Potential participants are patients referred to rehabilitation at five different Unicare rehabilitation centers in Norway (Unicare Helsefort, Unicare Coperio, Unicare Hokksund, Unicare Friskvern and Unicare Jeløy) due to long-term pain complaints.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rissa, Norway, 7112 Hasselvika
        • Unicare Helsefort

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Potential participants are patients referred to rehabilitation at five different Unicare rehabilitation centers in Norway (Unicare Helsefort, Unicare Coperio, Unicare Hokksund, Unicare Friskvern and Unicare Jeløy) due to long-term pain complaints. Potential participants are referred to outpatient or inpatient rehabilitation or a shorter assessment stay (where the goal is to assess what is the best treatment option for the patient). Referrals to the rehabilitation centers are done by the patients' general practitioner or by specialist healthcare. All referrals are considered at the regional unit for referrals (Regionalt henvisningsmottatak) in mid- or southeast Norway who judge whether they fulfill the criteria for rehabilitation in specialist health care.

Description

Inclusion Criteria:

  • Take part in rehabilitation for long-term pain complaints at one of the five centers
  • Consented to research

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Unicare Helsefort
Patients taking part in rehabilitation due to pain at Unicare Helsefort
Inpatient multimodal rehabilitation in specialist health care
Unicare Hokksund
Patients taking part in rehabilitation due to pain at Unicare Hokksund
Inpatient multimodal rehabilitation in specialist health care
Multimodal rehabilitation in specialist health care with program lasting whole work days
Unicare Coperio
Patients taking part in rehabilitation due to pain at Unicare Coperio
Multimodal rehabilitation in specialist health care with program lasting whole work days
Unicare Jeløy
Patients taking part in rehabilitation due to pain at Unicare Jeløy
Inpatient multimodal rehabilitation in specialist health care
Multimodal rehabilitation in specialist health care with program lasting whole work days
Unicare Friskvern
Patients taking part in rehabilitation due to pain at Unicare Friskvern
Multimodal rehabilitation in specialist health care with program lasting whole work days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia
Time Frame: Baseline
Measured by Insomnia severity index (ISI)
Baseline
Pain intensity
Time Frame: Baseline
Measured by visual analogue scale (0 to 100 scale)
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue
Time Frame: Baseline
Measured using a visual analogue scale from 0 to 100
Baseline
Function
Time Frame: Baseline
Measured by the patient-specific functional scale (PSFS)
Baseline
Physical activity
Time Frame: Baseline
Measured by questions from the HUNT study
Baseline
Workability
Time Frame: Baseline
Measured by the workability index single item (self- assessed work ability on a 0-10 scale)
Baseline
Prescriptions
Time Frame: Up to five years before rehabilitation and one year after rehabilitation
Use of sleep psychotropic medications, and pain medications based on registry data
Up to five years before rehabilitation and one year after rehabilitation
Sickness absence
Time Frame: Up to five years before rehabilitation and one year after rehabilitation
Use of medical benefits based on registry data
Up to five years before rehabilitation and one year after rehabilitation
Health care use
Time Frame: Up to five years before rehabilitation and one year after rehabilitation
Health care use in primary care based on registry data
Up to five years before rehabilitation and one year after rehabilitation
Health-related quality of life
Time Frame: Baseline
Measured by the the 5-level EQ-5D version (EQ-5D-5L) questionnaire. The index value range ranges from -0.285 to 1, where lower values indicate poorer health-related quality of life.
Baseline
Symptoms of anxiety and depression
Time Frame: Baseline
Measured by the Hopkins Symptom Checklist-25 (HSCL-25), mean score calculated (1-4)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Solveig K. Grudt, Msc, National Taiwan Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Actual)

July 31, 2025

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

June 24, 2024

First Submitted That Met QC Criteria

June 24, 2024

First Posted (Actual)

June 27, 2024

Study Record Updates

Last Update Posted (Estimated)

January 16, 2026

Last Update Submitted That Met QC Criteria

January 14, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Inpatient rehabilitation

Subscribe